References
- Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (Oxford). 1990;49:1374–403.
- Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49.
- Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.
- Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–14.
- van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.
- Parente F, Boemo C, Ardizzoia A, et al. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy. 2012;45:27–34.
- Klabunde C, Blom J, Bulliard J-L, et al. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22:119–26.
- Nielsen HJ, Jakobsen KV, Danish Study Group on Early Detection of Colorectal Cancer, et al. Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol. 2011;46:1283–94.
- Taber JM, Aspinwall LG, Heichman KA, et al. Preferences for blood-based colon cancer screening differ by race/ethnicity. Am J Health Behav. 2014;38:351–61.
- Nielsen HJ, Danish Endoscopy Study Group on Colorectal Cancer Detection, Danish Colorectal Cancer Cooperative Group, et al. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Scand J Gastroenterol. 2011;46:60–9.
- Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim Biophys Acta BBA Mol Basis Dis. 2014;1842:971–80.
- Ralla B, Stephan C, Meller S, et al. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. Crit Rev Clin Lab Sci. 2014;51:200–31.
- Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34:2357–62.
- Leszinski G, Gezer U, Siegele B, et al. Relevance of histone marks H3K9me3 and H4K20me3 in cancer. Anticancer Res. 2012;32:2199–205.
- Holdenrieder S, Von Pawel J, Nagel D, et al. Long-term stability of circulating nucleosomes in serum. Anticancer Res. 2010;30:1613–15.
- Holdenrieder S, Mueller S, Stieber P. Stability of nucleosomal DNA fragments in serum. Clin Chem. 2005;51:1026–9.
- Bulut O, Aslak KK, Levic K, et al. A randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery. Tech Coloproctol. 2015;19:11–22.
- Kirkwood T. Geometric means and measures of dispersion. Biometrics. 1979;35:908–9.
- Hayes DF, Bast RC, Desch CE, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996;88:1456–66.
- Frederiksen C, Lomholt AF, Davis GJ, et al. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. Anticancer Res. 2009;29:75–81.
- Holdenrieder S, Stieber P, Bodenmüller H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer J Int Cancer. 2001;95:114–20.